Clinical trial
A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative…
NCT00283946 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00283946 |
|---|---|
| Title | A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia |
| Official title | FK199B (Zolpidem MR Tablet) Phase III Clinical Study -A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia - |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders, Sleep Disorders |
| Intervention type | Drug |
| Interventions | Zolpidem MR, Zolpidem |
| Enrollment | 876 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jan 31, 2006 |
| Last update posted | Aug 20, 2014 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: